- Home
- WES vs PODD Comparison
WES vs PODD Comparison
Compare WES & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WES
- PODD
- Stock Information
- Founded
- WES 2007
- PODD 2000
- Country
- WES United States
- PODD United States
- Employees
- WES N/A
- PODD N/A
- Industry
- WES Natural Gas Distribution
- PODD Medical/Dental Instruments
- Sector
- WES Utilities
- PODD Health Care
- Exchange
- WES Nasdaq
- PODD Nasdaq
- Market Cap
- WES 15.7B
- PODD 17.2B
- IPO Year
- WES 2008
- PODD 2007
- Fundamental
- Price
- WES $37.10
- PODD $310.67
- Analyst Decision
- WES Hold
- PODD Buy
- Analyst Count
- WES 5
- PODD 18
- Target Price
- WES $38.60
- PODD $303.82
- AVG Volume (30 Days)
- WES 1.1M
- PODD 776.4K
- Earning Date
- WES 05-07-2025
- PODD 05-08-2025
- Dividend Yield
- WES 9.81%
- PODD N/A
- EPS Growth
- WES N/A
- PODD 67.51
- EPS
- WES 3.34
- PODD 5.55
- Revenue
- WES $3,634,610,000.00
- PODD $2,198,900,000.00
- Revenue This Year
- WES $6.26
- PODD $20.53
- Revenue Next Year
- WES $4.12
- PODD $17.42
- P/E Ratio
- WES $11.11
- PODD $55.96
- Revenue Growth
- WES 11.48
- PODD 23.48
- 52 Week Low
- WES $33.60
- PODD $160.19
- 52 Week High
- WES $43.33
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- WES 46.48
- PODD 72.94
- Support Level
- WES $35.25
- PODD $256.93
- Resistance Level
- WES $36.39
- PODD $260.96
- Average True Range (ATR)
- WES 0.96
- PODD 8.55
- MACD
- WES -0.03
- PODD 4.52
- Stochastic Oscillator
- WES 46.60
- PODD 97.95
About WES Western Midstream Partners LP Common Units Representing Limited Partner Interests
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.